Morisset Valerie
- SEC CIK
- 0001868517
No open-market purchases or sales filed in the past year.
Current role at each company
- CLYM Climb Bio, Inc.EVP, R&D AND CSOas of Jul 23, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Morisset Valerie as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 23, 2024 (view filing) | Jul 19-22 | 4 days | Morisset ValerieEVP, R&D AND CSO | SSale | −129.2K | $7.65 | −$988.5K | −80.5%31.3K after | 4 lots |
| Jul 19, 2024 (view filing) | Jul 17-18 | 2 days | Morisset ValerieEVP, R&D AND CSO | SSale | −41.8K | $6.93 | −$289.5K | −20.7%160.5K after | 2 lots |
| Jul 17, 2024 (view filing) | Jul 16 | 1 day | Morisset ValerieEVP, R&D AND CSO | SSale | −50.0K | $7.13 | −$356.5K | −19.8%202.3K after | |
| Jul 16, 2024 (view filing) | Jul 12-15 | 4 days | Morisset ValerieEVP, R&D AND CSO | SSale | −92.4K | $7.04 | −$650.6K | −26.8%252.3K after | 2 lots |
| Jul 11, 2024 (view filing) | Jul 9-11 | 2 days | Morisset ValerieEVP, R&D AND CSO | SSale | −105.9K | $6.95 | −$736.5K | −23.5%344.7K after | 3 lots |
| Jul 9, 2024 (view filing) | Jul 5 | 4 days | Morisset ValerieEVP, R&D AND CSO | SSale | −12.3K | $7.06 | −$87.1K | −2.7%450.6K after | |
| Jul 3, 2024 (view filing) | Jul 3 | Same day | Morisset ValerieEVP, R&D AND CSO | SSale | −50.0K | $6.76 | −$338.0K | −9.7%463.0K after |